Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparum

Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparum Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei- Infected Mice Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages Ex VivoActivity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates ofPlasmodium falciparumandP. vivax Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor